BioReference Laboratories, Inc. (NASDAQ:BRLI) has announced that it will release the fourth quarter earnings for 2009 on Thursday, December 17. BioReference President and Chief Executive Officer Marc Grodman M.D. will host a conference call at 10:30 am ET that morning to review the financial results. The call will be accessible via webcast on the company’s website, http://www.bioreference.com/. Listeners must register before they can listen to the webcast. The webcast will be archived on the site for thirty days following the conclusion of the presentation.
Top Best Penny Stocks, a leading financial publication, is pleased to alert investors of stocks on the move. Sign up for our Free Stock Newsletter.
Bio-Reference Laboratories, Inc. (Bio-Reference) is principally engaged in providing clinical laboratory testing services, primarily to customers in the greater New York metropolitan area, as well as to customers in a number of other states. Bio-Reference offers a list of chemical diagnostic tests, including blood and urine analysis, blood chemistry, hematology services, serology, radioimmuno analysis, toxicology (including drug screening), pap smears, tissue pathology (biopsies) and other tissue analysis. The Company operates two clinical laboratories, one in Elmwood Park, New Jersey and one in Valley Cottage, New York, and an andrology laboratory in New York City, a cytogenetics testing laboratory located in Milford, Massachusetts, a pathology laboratory in Poughkeepsie, New York, a pathology laboratory in Clarksburg, Maryland and a genetics laboratory in Gaithersburg, Maryland.
Sign up for Top Best Penny Stocks' free newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website.
Follow us on Twitter: http://www.Twitter.com/topbestps
About Us
Top Best Penny Stocks is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer.
